Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03356782 |
|
Recruitment Status : Unknown
Verified June 2020 by Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute.
Recruitment status was: Recruiting
First Posted : November 29, 2017
Last Update Posted : June 11, 2020
|
Sponsor:
Shenzhen Geno-Immune Medical Institute
Information provided by (Responsible Party):
Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | November 30, 2023 |
| Estimated Study Completion Date : | December 31, 2023 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):